InterMune Inc (ITMN)

neg -0.02
Today's Range: 73.81 - 73.99 | ITMN Avg Daily Volume: 3,940,800
Last Update: 09/26/14 - 4:00 PM EDT
Volume: 5,721,727
YTD Performance: 401.63%
Open: $73.91
Previous Close: $73.91
52 Week Range: $10.95 - $74.24
Oustanding Shares: 107,969,163
Market Cap: 7,977,841,454
6-Month Chart
TheStreet Ratings Grade for ITMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 7 8
Moderate Buy 0 0 0 0
Hold 6 6 1 2
Moderate Sell 0 0 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.20 2.20 1.56 1.64
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -28.42
Price Earnings Comparisons:
ITMN Sector Avg. S&P 500
-28.42 0.00 27.99
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
67.82% 393.59% 241.14%
Revenue 2.10 -0.46 -0.19
Net Income 0.00 0.59 0.00
EPS 0.00 -0.12 0.00
Earnings for ITMN:
Revenue 0.03B
Average Earnings Estimates

Earnings Estimates data is not available for ITMN.

Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Jim Cramer

 | Aug 25, 2014 | 6:51 AM EDT

The acquisition is a symbol of a much bigger trend.


Antonia Oprita

 | Aug 25, 2014 | 5:30 AM EDT

French government resigns; German business confidence falls.

bearishIntermune downgraded at Wells

Aug 21, 2014 | 7:19 AM EDT

ITMN was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call, as a potential takeover premium is largely baked into the stock. 

bearishIntermune downgraded at Goldman

Aug 14, 2014 | 6:54 AM EDT

ITMN was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $49 price target.


Bob Byrne

 | Jul 8, 2014 | 7:30 AM EDT

Don't batten down the hatches yet.

bullishIntermune upgraded at Leerink

May 19, 2014 | 8:15 AM EDT

ITMN was upgraded from Market Perform to Outperform, Leerink Swann said. $41 price target. Company posted better clinical data in two trials. 

bearishIntermune downgraded at Credit Suisse

Feb 28, 2014 | 8:09 AM EST

ITMN was downgraded from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $33 price target. 

bearishIntermune downgraded at Leerink

Feb 26, 2014 | 7:57 AM EST

ITMN was downgraded from Outperform to Market Perform, Leerink Swann said. Valuation call, based on a $41 price target. 


Bret Jensen

 | Oct 31, 2013 | 11:00 AM EDT

InterMune, Novavax have promising products and acquisition possibilities.

bullishIntermune upgraded at UBS

Jan 16, 2013 | 8:38 AM EST

ITMN was upgraded to Buy from Neutral, UBS said. $15 price target. Short term hurdles removed. 

we will add this here to cheaply protect our downside a bit BOUGHT SPY SEP...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.